Saturday, October 3, 2026

Palladium Futures Jumps By 5% In The Last 5 Sessions

Palladium Futures Jumps By 5% In The Last 5 Sessions

(VIANEWS) - Palladium (PA) has been up by 5.65% for the last 5 sessions. At 23:54 EST on Wednesday, 5 June, Palladium (PA) is $950.00.

Volume

Today's last reported volume for Palladium is 303, 99.99% below its average volume of 3409503303.44.

Volatility

Palladium's last week, last month's, and last quarter's current intraday variation average was 0.87%, 0.39%, and 1.89%, respectively.

Palladium's highest amplitude of average volatility was 2.22% (last week), 1.50% (last month), and 1.89% (last quarter), respectively.

Commodity Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Palladium's commodity is considered to be oversold (<=20).

News about

  • Crude oil extends declines as markets balk at opec+ plans to end production cuts. According to FXStreet on Tuesday, 4 June, "WTI has slid nearly 16% from 2024's peak bids above $87.00 per barrel, and US Crude Oil bids are up a scant 2.5% from the year's opening prices near $71.40.", "WTI tumbled to fresh multi-month lows near $72.50 on Tuesday, and US Crude Oil is grappling with chart territory south of $74.00 per barrel. "
  • Crude oil attempts to shrug off supplies buildup, WTI claws back to $74. According to FXStreet on Wednesday, 5 June, "As oil-heavy nations prepare to pivot away from OPEC+ production limits in favor of balancing their government budgets, Crude Oil markets are balking at the prospect of even further risks of oversupply as global demand fails to materialize in-line with energy market expectations.", "The Organization of the Petroleum Exporting Countries (OPEC) and its extended group of non-member ally states, OPEC+, cautioned this week that the global oil cartel is set to phasing out voluntary production cuts as Crude Oil producers grow frustrated at OPEC's inability to engineer broad-market support for barrel prices."

More news about Palladium (PA).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com